Cargando…

A pilot investigation of the prevalence of US-detectable forefoot joint pathology and reported foot-related disability in participants with systemic lupus erythematosus

BACKGROUND: The main aim of this study was to determine the prevalence of US-detectable forefoot bursae, metatarsophalangeal (MTP) joint and metacarpophalangeal (MCP) joint synovial hypertrophy (SH), Power Doppler (PD) signal or erosion in participants with systemic lupus erythematosus (SLE). A seco...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukherjee, Sandeep, Cherry, Lindsey, Zarroug, Jalaa, Culliford, David, Bowen, Catherine, Arden, Nigel, Edwards, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969688/
https://www.ncbi.nlm.nih.gov/pubmed/27486482
http://dx.doi.org/10.1186/s13047-016-0158-1
_version_ 1782445823966052352
author Mukherjee, Sandeep
Cherry, Lindsey
Zarroug, Jalaa
Culliford, David
Bowen, Catherine
Arden, Nigel
Edwards, Christopher
author_facet Mukherjee, Sandeep
Cherry, Lindsey
Zarroug, Jalaa
Culliford, David
Bowen, Catherine
Arden, Nigel
Edwards, Christopher
author_sort Mukherjee, Sandeep
collection PubMed
description BACKGROUND: The main aim of this study was to determine the prevalence of US-detectable forefoot bursae, metatarsophalangeal (MTP) joint and metacarpophalangeal (MCP) joint synovial hypertrophy (SH), Power Doppler (PD) signal or erosion in participants with systemic lupus erythematosus (SLE). A secondary aim was to determine the strength of potential association between patient reported foot-related disability and US-detected forefoot bursae, MTP joint SH, PD signal or erosion in participants with SLE. METHOD: A cross-sectional observational study of 20 participants with SLE was completed to determine the prevalence of US-detected forefoot bursal, MTP and MCP joint pathology. Patient-reported foot-related impairment and activity limitation (accumulatively referred to as disability) were also recorded. Spearmans’ Rank Correlation analyses were completed to determine the potential strength of association between US-detected pathology and patient report disability. RESULTS: The prevalence of MTP joint SH and PD was 80 % (16/20) and 10 % (2/20), respectively. The prevalence of MCP joint SH and PD was 60 % (12/20) and 30 % (6/20) respectively. A significant association was noted between PD scores for the MTP joints and MCP joints (r = 0.556; p = 0.011) although this was not demonstrated for SH scores (r = 0.176; p = 0.459). Significant associations between forefoot bursal prevalence and MTP joint PD were noted (r = 0.467; p = 0.038). The prevalence of bursae and bursal PD (grade 2 or above) was 100 % (20/20) and 10 % (2/20), respectively. Moderate foot-related impairment and activity limitation was reported by 95 and 85 % of participants respectively. CONCLUSION: This pilot study suggests that US-detected MTP, MCP joint and forefoot bursal abnormalities may be prevalent in participants with SLE and they may experience a moderate level of foot-related disability. Further research is required to substantiate these preliminary findings.
format Online
Article
Text
id pubmed-4969688
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49696882016-08-03 A pilot investigation of the prevalence of US-detectable forefoot joint pathology and reported foot-related disability in participants with systemic lupus erythematosus Mukherjee, Sandeep Cherry, Lindsey Zarroug, Jalaa Culliford, David Bowen, Catherine Arden, Nigel Edwards, Christopher J Foot Ankle Res Research BACKGROUND: The main aim of this study was to determine the prevalence of US-detectable forefoot bursae, metatarsophalangeal (MTP) joint and metacarpophalangeal (MCP) joint synovial hypertrophy (SH), Power Doppler (PD) signal or erosion in participants with systemic lupus erythematosus (SLE). A secondary aim was to determine the strength of potential association between patient reported foot-related disability and US-detected forefoot bursae, MTP joint SH, PD signal or erosion in participants with SLE. METHOD: A cross-sectional observational study of 20 participants with SLE was completed to determine the prevalence of US-detected forefoot bursal, MTP and MCP joint pathology. Patient-reported foot-related impairment and activity limitation (accumulatively referred to as disability) were also recorded. Spearmans’ Rank Correlation analyses were completed to determine the potential strength of association between US-detected pathology and patient report disability. RESULTS: The prevalence of MTP joint SH and PD was 80 % (16/20) and 10 % (2/20), respectively. The prevalence of MCP joint SH and PD was 60 % (12/20) and 30 % (6/20) respectively. A significant association was noted between PD scores for the MTP joints and MCP joints (r = 0.556; p = 0.011) although this was not demonstrated for SH scores (r = 0.176; p = 0.459). Significant associations between forefoot bursal prevalence and MTP joint PD were noted (r = 0.467; p = 0.038). The prevalence of bursae and bursal PD (grade 2 or above) was 100 % (20/20) and 10 % (2/20), respectively. Moderate foot-related impairment and activity limitation was reported by 95 and 85 % of participants respectively. CONCLUSION: This pilot study suggests that US-detected MTP, MCP joint and forefoot bursal abnormalities may be prevalent in participants with SLE and they may experience a moderate level of foot-related disability. Further research is required to substantiate these preliminary findings. BioMed Central 2016-08-02 /pmc/articles/PMC4969688/ /pubmed/27486482 http://dx.doi.org/10.1186/s13047-016-0158-1 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Mukherjee, Sandeep
Cherry, Lindsey
Zarroug, Jalaa
Culliford, David
Bowen, Catherine
Arden, Nigel
Edwards, Christopher
A pilot investigation of the prevalence of US-detectable forefoot joint pathology and reported foot-related disability in participants with systemic lupus erythematosus
title A pilot investigation of the prevalence of US-detectable forefoot joint pathology and reported foot-related disability in participants with systemic lupus erythematosus
title_full A pilot investigation of the prevalence of US-detectable forefoot joint pathology and reported foot-related disability in participants with systemic lupus erythematosus
title_fullStr A pilot investigation of the prevalence of US-detectable forefoot joint pathology and reported foot-related disability in participants with systemic lupus erythematosus
title_full_unstemmed A pilot investigation of the prevalence of US-detectable forefoot joint pathology and reported foot-related disability in participants with systemic lupus erythematosus
title_short A pilot investigation of the prevalence of US-detectable forefoot joint pathology and reported foot-related disability in participants with systemic lupus erythematosus
title_sort pilot investigation of the prevalence of us-detectable forefoot joint pathology and reported foot-related disability in participants with systemic lupus erythematosus
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969688/
https://www.ncbi.nlm.nih.gov/pubmed/27486482
http://dx.doi.org/10.1186/s13047-016-0158-1
work_keys_str_mv AT mukherjeesandeep apilotinvestigationoftheprevalenceofusdetectableforefootjointpathologyandreportedfootrelateddisabilityinparticipantswithsystemiclupuserythematosus
AT cherrylindsey apilotinvestigationoftheprevalenceofusdetectableforefootjointpathologyandreportedfootrelateddisabilityinparticipantswithsystemiclupuserythematosus
AT zarrougjalaa apilotinvestigationoftheprevalenceofusdetectableforefootjointpathologyandreportedfootrelateddisabilityinparticipantswithsystemiclupuserythematosus
AT culliforddavid apilotinvestigationoftheprevalenceofusdetectableforefootjointpathologyandreportedfootrelateddisabilityinparticipantswithsystemiclupuserythematosus
AT bowencatherine apilotinvestigationoftheprevalenceofusdetectableforefootjointpathologyandreportedfootrelateddisabilityinparticipantswithsystemiclupuserythematosus
AT ardennigel apilotinvestigationoftheprevalenceofusdetectableforefootjointpathologyandreportedfootrelateddisabilityinparticipantswithsystemiclupuserythematosus
AT edwardschristopher apilotinvestigationoftheprevalenceofusdetectableforefootjointpathologyandreportedfootrelateddisabilityinparticipantswithsystemiclupuserythematosus
AT mukherjeesandeep pilotinvestigationoftheprevalenceofusdetectableforefootjointpathologyandreportedfootrelateddisabilityinparticipantswithsystemiclupuserythematosus
AT cherrylindsey pilotinvestigationoftheprevalenceofusdetectableforefootjointpathologyandreportedfootrelateddisabilityinparticipantswithsystemiclupuserythematosus
AT zarrougjalaa pilotinvestigationoftheprevalenceofusdetectableforefootjointpathologyandreportedfootrelateddisabilityinparticipantswithsystemiclupuserythematosus
AT culliforddavid pilotinvestigationoftheprevalenceofusdetectableforefootjointpathologyandreportedfootrelateddisabilityinparticipantswithsystemiclupuserythematosus
AT bowencatherine pilotinvestigationoftheprevalenceofusdetectableforefootjointpathologyandreportedfootrelateddisabilityinparticipantswithsystemiclupuserythematosus
AT ardennigel pilotinvestigationoftheprevalenceofusdetectableforefootjointpathologyandreportedfootrelateddisabilityinparticipantswithsystemiclupuserythematosus
AT edwardschristopher pilotinvestigationoftheprevalenceofusdetectableforefootjointpathologyandreportedfootrelateddisabilityinparticipantswithsystemiclupuserythematosus